Abbott to Spin Off $8.5 Billion Nutrition Business by End of 2027
Abbott will spin its $8.5B nutrition unit — Pedialyte, Similac, Ensure — into a public company by end of 2027, keeping a $42B devices and diagnostics core amid lingering formula litigation.